Journal
CHEMICAL SCIENCE
Volume 6, Issue 10, Pages 5969-5977Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5sc01721a
Keywords
-
Categories
Funding
- National Basic Research Program [2014CB744501]
- National Science Fund for Creative Research Groups [21121091]
- National Natural Science Foundation of China [21135002, 91413118, 21322506, 91213301, 21371090]
- Priority development areas of The National Research Foundation for the Doctoral Program of Higher Education of China [20130091130005]
Ask authors/readers for more resources
This work reports a newly designed pH-activatable and aniline-substituted aza-boron-dipyrromethene as a trifunctional photosensitizer to achieve highly selective tumor imaging, efficient photodynamic therapy (PDT) and therapeutic self-monitoring through encapsulation in a cRGD-functionalized nanomicelle. The diethylaminophenyl is introduced in to the structure for pH-activatable near-infrared fluorescence and singlet oxygen (O-1(2)) generation, and bromophenyl is imported to increase the O-1(2) generation efficiency upon pH activation by virtue of its heavy atom effect. After encapsulation, the nanoprobe can target alpha(v)beta(3) integrin-rich tumor cells via cRGD and is activated by physiologically acidic pH for cancer discrimination and PDT. The fascinating advantage of the nanoprobe is near-infrared implementation beyond 800 nm, which significantly improves the imaging sensitivity and increases the penetration depth of the PDT. By monitoring the fluorescence decrease in the tumor region after PDT, the therapeutic efficacy is demonstrated in situ and in real time, which provides a valuable and convenient self-feedback function for PDT efficacy tracking. Therefore, this rationally designed and carefully engineered nanoprobe offers a new paradigm for precise tumor theranostics and may provide novel opportunities for future clinical cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available